Cargando…

Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Naylor, Kyla L., McArthur, Eric, Dixon, Stephanie N., Kwong, Jeffrey C., Thomas, Doneal, Balamchi, Shabnam, Blake, Peter G., Garg, Amit X., Atiquzzaman, Mohammad, Hladunewich, Michelle A., Levin, Adeera, Yeung, Angie, Oliver, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier, Inc., on behalf of the International Society of Nephrology. 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886430/ https://www.ncbi.nlm.nih.gov/pubmed/36731610 http://dx.doi.org/10.1016/j.kint.2023.01.009

Ejemplares similares

COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces
por: Atiquzzaman, Mohammad, et al.
Publicado: (2023)

COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada
por: Atiquzzaman, Mohammad, et al.
Publicado: (2022)

Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis
por: Yau, Kevin, et al.
Publicado: (2022)

Différences d’immunogénicité des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialysés
por: Yau, Kevin, et al.
Publicado: (2022)

Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes
por: Roushani, Jian, et al.
Publicado: (2021)

Comparison of All-Cause Mortality Between Canadian Kidney Transplant Recipients and Patients With Cancer: A Population-Based Cohort Study
por: Naylor, Kyla L., et al.
Publicado: (2021)

Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients
por: McEvoy, Caitríona M., et al.
Publicado: (2022)

Projecting the Number of Posttransplant Clinic Visits With a Rise in the Number of Kidney Transplants: A Case Study From Ontario, Canada
por: Mann, Shawna, et al.
Publicado: (2020)

Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study
por: Yi, Tae Won, et al.
Publicado: (2022)

Outcomes of an Inpatient Dialysis Start in Patients With Kidney Graft Failure: A Population-Based Multicentre Cohort Study
por: Naylor, Kyla L., et al.
Publicado: (2021)

Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada
por: Atiquzzaman, Mohammad, et al.
Publicado: (2022)

COVID-19 in patients undergoing long-term dialysis in Ontario
por: Taji, Leena, et al.
Publicado: (2021)

COVID-19 chez les patients ontariens sous dialyse à long terme
por: Taji, Leena, et al.
Publicado: (2021)

Evaluation of a Hockey Deceased Organ Donation Awareness Campaign: A Population-Based Cohort Study
por: Naylor, Kyla L., et al.
Publicado: (2017)

POS-975 SEROLOGIC RESPONSE TO THE mRNA-1273 and BNT162b2 COVID-19 VACCINES IN DIALYSIS PATIENTS
por: Yau, K., et al.
Publicado: (2022)

Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease
por: Yau, Kevin, et al.
Publicado: (2023)

Predicting 3-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation of iChoose Kidney in Ontario, Canada
por: Tan, Vivian S., et al.
Publicado: (2018)

Risk Factors and Outcomes of Early Hospital Readmission in Canadian Kidney Transplant Recipients: A Population-Based Multi-Center Cohort Study
por: Naylor, Kyla L., et al.
Publicado: (2021)

Using Administrative Health Care Databases to Identify Patients With End-Stage Kidney Disease With No Recorded Contraindication to Receiving a Kidney Transplant
por: Wang, Carol, et al.
Publicado: (2022)

Frequency of bone mineral density testing in adult kidney transplant recipients from Ontario, Canada: a population-based cohort study
por: Naylor, Kyla L., et al.
Publicado: (2016)

Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study
por: Lam, Ngan N, et al.
Publicado: (2014)

Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)

Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics
por: McArthur, Monica A.
Publicado: (2017)

Double-Positive Anti–Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients
por: Ting, Julie Anne, et al.
Publicado: (2023)

Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol
por: Yau, Kevin, et al.
Publicado: (2023)

Variation in Kidney Transplant Referral Across Chronic Kidney Disease Programs in Ontario, Canada
por: Yohanna, Seychelle, et al.
Publicado: (2023)

Simple compared to covariate-constrained randomization methods in balancing baseline characteristics: a case study of randomly allocating 72 hemodialysis centers in a cluster trial
por: Al-Jaishi, Ahmed A., et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine-Associated Myocarditis
por: Kyaw, Htin, et al.
Publicado: (2022)

Comparing Five Comorbidity Indices to Predict Mortality in Chronic Kidney Disease: A Retrospective Cohort Study
por: McArthur, Eric, et al.
Publicado: (2018)

Rationale for a home dialysis virtual ward: design and implementation
por: Schachter, Michael E, et al.
Publicado: (2014)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
por: Agha, Mounzer, et al.
Publicado: (2021)

A Province-wide, Cross-sectional Study of Demographics and Medication Use of Patients in Hemodialysis Units Across Ontario
por: Battistella, Marisa, et al.
Publicado: (2018)

Potential of mRNA vaccines to become versatile cancer vaccines
por: Tsao, Shiu-Ying
Publicado: (2022)

Predictors of progression to chronic dialysis in survivors of severe acute kidney injury: a competing risk study
por: Harel, Ziv, et al.
Publicado: (2014)

Is the Kidney Donor Risk Index a Useful Tool in Non-US Patients?
por: Young, Ann, et al.
Publicado: (2018)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p30qs9locvjq6ajlfqrctk4cf8